Name | Symbol | Markt | Aktientyp |
---|---|---|---|
CTI BioPharma Corporation | CTIC | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
9,09 | 9,09 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
06.7.2023 | 22:15 | EDGAR2 | Form 15-12G - Securities registration termination [Section.. |
30.6.2023 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
29.6.2023 | 00:26 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
28.6.2023 | 19:51 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
24.6.2023 | 12:51 | PRNUS | Sobi successfully completes tender offer for all outstanding.. |
24.6.2023 | 12:49 | PRNUS | Sobi successfully completes tender offer for all outstanding.. |
30.5.2023 | 22:35 | PRNUS | CTI BioPharma Announces Cancellation of its 2023 Annual.. |
10.5.2023 | 07:06 | PRNUS | Sobi to Acquire CTI BioPharma |
05.5.2023 | 01:55 | PRNUS | CTI BioPharma Announces Inducement Grants Under Nasdaq.. |
02.5.2023 | 22:35 | PRNUS | CTI BioPharma Announces Inducement Grants Under Nasdaq.. |
01.5.2023 | 22:46 | PRNUS | CTI BioPharma To Report First Quarter 2023 Financial Results.. |
01.5.2023 | 13:03 | PRNUS | CTI BioPharma Announces Two Abstracts Accepted for.. |